Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New malaria vaccine trial shows lack of efficacy

Sep. 18, 2015

Otsuka launches Olanedine antiseptic

Sep. 18, 2015

Viamet's VT-1129 obtains FDA's QIDP designation for cryptococcal meningitis

Sep. 17, 2015

Chinese team presents anti-HCV agents

Sep. 17, 2015

Malaria vaccine shows promising preliminary safety results

Sep. 17, 2015

Sichuan Haisco Pharmaceutical reports phosphoramidate antivirals

Sep. 16, 2015

Laboratoire Biodim discloses dltA inhibitors

Sep. 16, 2015

BARDA funding awarded to Crucell Holland to accelerate Ebola vaccine program

Sep. 16, 2015

Nucleic acid antibody prophylaxis as an antiviral immunotherapy for dengue

Sep. 16, 2015

DNDi and Eisai partner to develop fosravuconazole for eumycetoma

Sep. 15, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...